↑ トップへ ← 戻る

 Drug(薬物リスト) DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

125 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   20 mg bid of pf-02545920   -   -   -   -   1件:
8 
 2   20mg daily citalopram   Citalopram   D00822, D07704   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
8 
 3   [123i]mni-420   -   -   -   -   2件:
6,
8 
 4   [18f]fpeb   -   -   -   -   3件:
6,
8,
206 
 5   Acr16   Acr16   -   -   -   1件:
8 
 6   Acr16 10 mg   Acr16   -   -   -   1件:
8 
 7   Acr16 22.5 mg   Acr16   -   -   -   1件:
8 
 8   Acr16 45 mg   Acr16   -   -   -   1件:
8 
 9   Acr16 hydrochloride, asp2314 hydrochloride, fr310826   Acr16   -   -   -   1件:
8 
 10   Afq056   -   -   -   -   3件:
6,
8,
206 
 11   Alprazolam   Alprazolam   D00225   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   1件:
8 
 12   Amantadine   Amantadine   D00777, D07441   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   4件:
6,
8,
13,
127 
 13   Atomoxetine   Atomoxetine   D02574, D07473   1件: SLC6A2   1件: Synaptic vesicle cycle   3件:
6,
8,
13 
 14   Autologous stem cell   -   -   -   -   1件:
8 
 15   Bevantolol   Bevantolol   -   -   -   1件:
8 
 16   Bevantolol hydrochloride   Bevantolol   -   -   -   1件:
8 
 17   Blood sample   -   -   -   -   12件:
8,
13,
46,
49,
51,
53,
61,
66,
97,
274,
288,
299 
 18   Bn82451b   -   -   -   -   1件:
8 
 19   Bn8251b   -   -   -   -   1件:
8 
 20   Bupropion   Bupropion   D00817, D07591, D07938   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   2件:
8,
96 
 21   Calvan® 100 mg   -   -   -   -   1件:
8 
 22   Cellavita hd higher dose   -   -   -   -   1件:
8 
 23   Cellavita hd lower dose   -   -   -   -   1件:
8 
 24   Citalopram   Citalopram   D00822, D07704   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
8,
46,
127 
 25   Coenzyme q10   Ubidecarenone   D01065   -   -   10件:
2,
6,
8,
10,
46,
57,
113,
193,
214,
215 
 26   Coq10   Ubidecarenone   D01065   -   -   3件:
5,
6,
8 
 27   Creatine   Creatine   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201 
 28   Creatine monohydrate   Creatine   -   -   -   4件:
2,
8,
113,
156 
 29   Cystagon   Cysteamine   D03634, D03635   -   -   3件:
8,
19,
299 
 30   Cysteamine   Cysteamine   D03634, D03635   -   -   4件:
8,
19,
21,
299 
 31   Cysteamine bitartrate   Cysteamine   D03634, D03635   -   -   4件:
8,
19,
21,
299 
 32   Dextromethorphan   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156 
 33   Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg)   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 34   Digoxin   Digoxin   D00298   4件: ATP1A1, ATP1A2, ATP1A3, ATP1A4   18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
8,
46 
 35   Dimebon   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 36   Dimebon (latrepirdine)   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 37   Dimebon + dextromethorphan   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 38   Dimebon + ketoconazole   Ketoconazole   D00351   1件: CYP17A1   6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis   1件:
8 
 39   Dimebon + omeprazole   Omeprazole   D00455, D01207, D05259, D05261   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   1件:
8 
 40   Dimebon alone   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 41   Dimebon dihydrochloride   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 42   Dimebon ir   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 43   Dimebon ir tablet   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 44   Dimebon mr1   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 45   Dimebon mr2   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 46   Dimebon mr3   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 47   Dimebon mr4   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 48   Dimebon transdermal   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 49   Divalproex   Valproic acid   D00399   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   1件:
8 
 50   Ethyl-epa   Icosapent ethyl   D01892   -   -   1件:
8 
 51   Ethyl-epa (miraxion™)   Icosapent ethyl   D01892   -   -   1件:
8 
 52   Fenofibrate   Fenofibrate   D00565   1件: PPARA   7件: Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   5件:
8,
79,
93,
94,
265 
 53   Graft intracerebral of foetal neurons   -   -   -   -   1件:
8 
 54   Gsk356278   Gsk356278   -   -   -   1件:
8 
 55   Haloperidol   Haloperidol   D00136, D01898   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
8 
 56   Hyperium   Rilmenidine   D08482   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
8 
 57   Isis 443139 10 mg   -   -   -   -   1件:
8 
 58   Isis 443139 120 mg   -   -   -   -   1件:
8 
 59   Isis 443139 30 mg   -   -   -   -   1件:
8 
 60   Isis 443139 60 mg   -   -   -   -   1件:
8 
 61   Isis 443139 90 mg   -   -   -   -   1件:
8 
 62   Ketoconazole   Ketoconazole   D00351   1件: CYP17A1   6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis   3件:
8,
13,
75 
 63   Laquinimod   Laquinimod   -   -   -   4件:
8,
13,
49,
96 
 64   Latrepirdine   Latrepirdine   D09917   6件: ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   19件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   1件:
8 
 65   Lax-101   -   -   -   -   1件:
8 
 66   Lithium   Lithium citrate   D04749   -   -   4件:
2,
5,
7,
8 
 67   Memantine   Memantine   D04905, D08174   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   7件:
2,
6,
8,
13,
49,
127,
205 
 68   Minocycline   Minocycline   D00850, D05045   -   -   13件:
2,
6,
8,
13,
46,
85,
90,
94,
162,
201,
206,
280,
299 
 69   N.a.   -   -   -   -   8件:
3,
6,
8,
13,
46,
97,
240,
256 
 70   Neflamapimod   Neflamapimod   D10959   4件: MAPK11, MAPK12, MAPK13, MAPK14   53件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis (ALS), C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease (American trypanosomiasis), Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pertussis, Platelet activation, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection   1件:
8 
 71   Nilotinib   Nilotinib   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   5件:
6,
8,
34,
51,
86 
 72   Nilotinib 150 mg   Nilotinib   D08953   4件: ABL1, KIT, PDGFRA, PDGFRB   33件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Viral myocarditis   1件:
8 
 73   Olanzapine   Olanzapine   D00454, D06623   11件: ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6   16件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
2,
8 
 74   Omeprazole   Omeprazole   D00455, D01207, D05259, D05261   2件: ATP4A, ATP4B   4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation   15件:
6,
8,
13,
46,
51,
85,
96,
97,
98,
225,
271,
282,
294,
298,
299 
 75   Osu6162 similar to (-)-osu 6162   -   -   -   -   2件:
6,
8 
 76   Pbf-999   -   -   -   -   1件:
8 
 77   Pbf-999 / 160 mg   -   -   -   -   1件:
8 
 78   Pbf-999 / 320 mg   -   -   -   -   1件:
8 
 79   Pbt2   -   -   -   -   1件:
8 
 80   Pf-02545920   -   -   -   -   1件:
8 
 81   Phenylbutyrate   Phenylbutyric acid   D05868   -   -   10件:
2,
3,
6,
8,
93,
94,
244,
251,
297,
299 
 82   Phosphorus   Phosphorus   -   -   -   1件:
8 
 83   Pridopidine   Pridopidine   D09953   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   2件:
6,
8 
 84   Pridopidine (90 mg)   Pridopidine   D09953   1件: DRD2   8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway   1件:
8 
 85   Quinidine   Quinidine   D00642, D00643, D02272, D08458   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   3件:
2,
8,
13 
 86   Ramelteon   Ramelteon   D02689   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   3件:
6,
8,
46 
 87   Resveratrol   Resveratrol   -   -   -   3件:
8,
89,
113 
 88   Rg6042, formerly isis 443139, ionis-httrx   -   -   -   -   1件:
8 
 89   Rilmenidine   Rilmenidine   D08482   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   1件:
8 
 90   Riluzole   Riluzole   D00775   14件: GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway   7件:
2,
3,
5,
8,
13,
17,
206 
 91   Risperidone   Risperidone   D00426   2件: DRD2, HTR2A   11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway   5件:
8,
156,
179,
187,
206 
 92   Ro 723-4292/f02   -   -   -   -   1件:
8 
 93   Ro7234292   -   -   -   -   1件:
8 
 94   Ro7234292 (rg6042)   -   -   -   -   1件:
8 
 95   Rolipram   Rolipram   D01783   4件: PDE4A, PDE4B, PDE4C, PDE4D   5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway   2件:
8,
13 
 96   Rp 103   -   -   -   -   2件:
8,
19 
 97   Rp103   -   -   -   -   2件:
8,
19 
 98   Sage   Sage   -   -   -   2件:
6,
8 
 99   Sage-718   Sage   -   -   -   1件:
8 
 100   Sbt-020   -   -   -   -   1件:
8 
 101   Sd-809   -   -   -   -   1件:
8 
 102   Selisistat   Selisistat   -   -   -   1件:
8 
 103   Sen0014196   -   -   -   -   1件:
8 
 104   Sodium phenylbutyrate   Phenylbutyric acid   D05868   -   -   4件:
2,
3,
8,
251 
 105   Som3355 100mg bid   -   -   -   -   1件:
8 
 106   Som3355 200mg bid   -   -   -   -   1件:
8 
 107   Srx246   -   -   -   -   1件:
8 
 108   Ss-20   -   -   -   -   1件:
8 
 109   Tetrabenazine   Tetrabenazine   D08575   1件: SLC18A2   7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle   1件:
8 
 110   Tetrabenazine withdrawal   Tetrabenazine   D08575   1件: SLC18A2   7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle   1件:
8 
 111   Tiapridal   -   -   -   -   1件:
8 
 112   Triheptanoin   Triheptanoin   D11465   -   -   10件:
2,
8,
120,
149,
156,
248,
256,
257,
317,
324 
 113   Triheptanoin 1g/kg/day   Triheptanoin   D11465   -   -   1件:
8 
 114   Triheptanoin oil   Triheptanoin   D11465   -   -   1件:
8 
 115   Tv-7820   -   -   -   -   1件:
8 
 116   Ubiquinol   Ubiquinol   -   -   -   3件:
6,
8,
17 
 117   Ursodiol   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   6件:
8,
20,
93,
97,
234,
299 
 118   Ux007   -   -   -   -   4件:
8,
248,
256,
257 
 119   Valbenazine   Valbenazine   D10675   1件: SLC18A2   7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle   1件:
8 
 120   Vx15/2503   Pepinemab   D11469   1件: SEMA4D   1件: Axon guidance   2件:
8,
13 
 121   Warfarin   Warfarin   D00564, D01280, D08682   2件: NQO1, VKORC1   5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   10件:
6,
8,
13,
19,
46,
49,
66,
85,
88,
96 
 122   Wve-120101   -   -   -   -   1件:
8 
 123   Wve-120102   -   -   -   -   1件:
8 
 124   Xenazine   Tetrabenazine   D08575   1件: SLC18A2   7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle   1件:
8 
 125   Zoloft   Sertraline   D00825, D02360   1件: SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   1件:
8 

先頭へ